MedPath

Malignant external otitis – evaluation of prognostic factors

Conditions
H60.2
Malignant otitis externa
Registration Number
DRKS00025149
Lead Sponsor
HNO-Uniklinik Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
200
Inclusion Criteria

Treatment for external otitis maligna at Freiburg University Hospital between 2000 and 2020. The presence of otitis externa maligna is defined according to the criteria of Cohen and Friedman (1987).

Exclusion Criteria

Age under 18 years

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of prognostic factors for improvement of the leading symptom in patients* with otitis externa maligna.
Secondary Outcome Measures
NameTimeMethod
(a) Identification of prognostic factors for the duration of antibiotic infusion therapy.<br>(b) Influence of different therapy options (antibiotic therapy, surgery, HbO therapy) and therapy combinations on the improvement of the leading symptom in patients with otitis externa maligna.
© Copyright 2025. All Rights Reserved by MedPath